HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Yu Chen Selected Research

protein kinase P

4/2022Bicalutamide may enhance kidney injury in diabetes by concomitantly damaging energy production from OXPHOS and glycolysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Yu Chen Research Topics

Disease

9Neoplasms (Cancer)
12/2021 - 10/2004
6Primary Effusion Lymphoma
12/2017 - 10/2004
4Fibrosis (Cirrhosis)
04/2022 - 01/2019
4Prostatic Neoplasms (Prostate Cancer)
04/2022 - 01/2019
3Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 05/2020
3Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 11/2020
2Hypoxia (Hypoxemia)
04/2022 - 05/2020
2Nasopharyngeal Carcinoma
03/2018 - 09/2015
2Multi-centric Castleman's Disease
12/2004 - 10/2004
2Kaposi Sarcoma (Kaposi's Sarcoma)
12/2004 - 10/2004
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
12/2021
1Acute Kidney Injury (Acute Renal Failure)
12/2021
1Circulating Neoplastic Cells
12/2021
1Chronic Renal Insufficiency
06/2020
1Hypertension (High Blood Pressure)
04/2020
1Kidney Diseases (Kidney Disease)
03/2019
1Obesity
03/2019
1Renal Insufficiency (Renal Failure)
03/2019
1Latent Infection
12/2015
1Carcinogenesis
09/2015
1Lymphoma (Lymphomas)
05/2012
1Hepatocellular Carcinoma (Hepatoma)
12/2010
1Thrombocytopenia (Thrombopenia)
09/2010

Drug/Important Bio-Agent (IBA)

4bicalutamide (Casodex)FDA LinkGeneric
04/2022 - 01/2019
4imidazole mustard (BIC)IBA
04/2022 - 01/2019
4AndrogensIBA
04/2022 - 01/2019
3Pharmaceutical PreparationsIBA
12/2021 - 12/2015
2HMGN1 Protein (HMGN1)IBA
10/2021 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
11/2020 - 05/2012
2LipidsIBA
06/2020 - 03/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 03/2018
2Annexin A2 (Annexin II)IBA
03/2018 - 09/2015
2A-Form DNA (A-DNA)IBA
12/2004 - 10/2004
1Adenosine Triphosphate (ATP)IBA
04/2022
1protein kinase PIBA
04/2022
1SirtuinsIBA
12/2021
1NADPH Oxidase 4IBA
12/2021
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2021
1PlatinumIBA
12/2021
1Small Cytoplasmic RNAIBA
10/2021
1Peptides (Polypeptides)IBA
10/2021
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
10/2021
1Therapeutic UsesIBA
11/2020
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
06/2020
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2020
1Acetyl-CoA CarboxylaseIBA
06/2020
1Messenger RNA (mRNA)IBA
05/2020
1Biomarkers (Surrogate Marker)IBA
03/2019
1Platelet-Derived Growth FactorIBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1CollagenIBA
01/2019
1Fibronectins (Fibronectin)IBA
01/2019
1AnnexinsIBA
03/2018
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2017
1TeaIBA
12/2017
1ResveratrolIBA
12/2015
1Plasminogen Activator Inhibitor 1IBA
12/2010
1Hemostatics (Antihemorrhagics)IBA
09/2010
1Butyric Acid (Butanoic Acid)IBA
04/2006
1StaurosporineIBA
12/2004
1Paclitaxel (Taxol)FDA LinkGeneric
10/2004
1CaspasesIBA
10/2004

Therapy/Procedure

6Therapeutics
04/2022 - 03/2018
3Immunotherapy
10/2021 - 03/2018
3Drug Therapy (Chemotherapy)
01/2021 - 03/2018
1Radiotherapy
03/2018